US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 26.230
  • +0.280+1.08%
Close Dec 26 16:00 ET
2.74BMarket Cap-11.87P/E (TTM)

NewAmsterdam Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
889.83%29.11M
32.73%2.28M
-83.76%1.4M
-86.28%14.09M
803K
2.94M
1.72M
8.63M
102.69M
0
Operating revenue
889.83%29.11M
32.73%2.28M
-83.76%1.4M
-86.28%14.09M
--803K
--2.94M
--1.72M
--8.63M
--102.69M
--0
Cost of revenue
Gross profit
Operating expense
3.43%52.98M
31.83%53.68M
18.48%55.99M
87.77%189.2M
50M
51.22M
40.72M
47.26M
190.78%100.76M
433.78%34.65M
Selling and administrative expenses
120.01%17.28M
139.97%15.3M
98.33%13.56M
112.42%29.77M
--8.71M
--7.85M
--6.38M
--6.84M
146.87%14.02M
274.65%5.68M
-Selling and marketing expense
210.51%3.55M
650.96%3.52M
559.39%4.08M
137.33%4.06M
--1.83M
--1.14M
--469K
--618K
74.92%1.71M
7,121.27%977K
-General and administrative expense
104.60%13.73M
99.39%11.78M
52.52%9.49M
108.96%25.72M
--6.88M
--6.71M
--5.91M
--6.22M
161.83%12.31M
212.96%4.7M
Research and development costs
-17.68%35.7M
11.76%38.38M
4.97%42.43M
83.79%159.42M
--41.29M
--43.37M
--34.34M
--40.42M
199.39%86.74M
482.37%28.97M
Operating profit
50.57%-23.87M
-31.79%-51.4M
-41.32%-54.59M
-9,149.35%-175.11M
-49.2M
-48.28M
-39M
-38.63M
105.58%1.94M
-433.78%-34.65M
Net non-operating interest income expense
85.43%3.31M
226.81%3.69M
876.60%2.19M
159.20%3.42M
789K
1.78M
1.13M
-282K
-684.12%-5.78M
-21.05%-737K
Non-operating interest income
45.24%4.44M
5.57%4.87M
226.94%3.08M
--11.28M
--2.67M
--3.06M
--4.61M
--943K
--0
--0
Non-operating interest expense
----
----
----
--0
----
----
----
----
-30.17%287K
-2.86%411K
Total other finance cost
-10.98%1.14M
-66.21%1.18M
-27.10%893K
43.15%7.86M
--1.88M
--1.28M
--3.48M
--1.23M
1,584.66%5.49M
75.53%326K
Other net income (expense)
717.03%3.91M
2,161.14%8.7M
-1,231.02%-41.37M
72.19%-5.23M
-1.06M
-634K
-422K
-3.11M
-193.73%-18.79M
-21,770.90%-6.4M
Gain on sale of security
717.03%3.91M
2,161.14%8.7M
-1,231.02%-41.37M
51.56%-5.23M
---1.06M
---634K
---422K
---3.11M
-732.36%-10.79M
5,679.36%1.71M
Special income (charges)
----
----
----
--0
----
----
----
----
--0
---883K
-Less:Other special charges
----
----
----
----
----
----
----
----
----
--883K
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
-10.83%-8M
---7.22M
Income before tax
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
-681.61%-176.91M
-49.47M
-47.13M
-38.29M
-42.02M
45.83%-22.63M
-490.94%-41.79M
Income tax
-1K
0
0
27K
27K
0
0
0
0
0
Net income
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
-681.73%-176.94M
-49.5M
-47.13M
-38.29M
-42.02M
45.83%-22.63M
-490.94%-41.79M
Net income continuous Operations
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
-681.73%-176.94M
---49.5M
---47.13M
---38.29M
---42.02M
45.83%-22.63M
-490.94%-41.79M
Minority interest income
Net income attributable to the parent company
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
-681.73%-176.94M
-49.5M
-47.13M
-38.29M
-42.02M
45.83%-22.63M
-490.94%-41.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
-681.73%-176.94M
-49.5M
-47.13M
-38.29M
-42.02M
45.83%-22.63M
-490.94%-41.79M
Basic earnings per share
68.42%-0.18
12.77%-0.41
-107.84%-1.06
-80.67%-2.15
-0.6
-0.57
-0.47
-0.51
-132.27%-1.19
-490.94%-0.5123
Diluted earnings per share
68.42%-0.18
12.77%-0.41
-107.84%-1.06
-80.67%-2.15
-0.6
-0.57
-0.47
-0.51
-132.27%-1.19
-490.94%-0.5123
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 889.83%29.11M32.73%2.28M-83.76%1.4M-86.28%14.09M803K2.94M1.72M8.63M102.69M0
Operating revenue 889.83%29.11M32.73%2.28M-83.76%1.4M-86.28%14.09M--803K--2.94M--1.72M--8.63M--102.69M--0
Cost of revenue
Gross profit
Operating expense 3.43%52.98M31.83%53.68M18.48%55.99M87.77%189.2M50M51.22M40.72M47.26M190.78%100.76M433.78%34.65M
Selling and administrative expenses 120.01%17.28M139.97%15.3M98.33%13.56M112.42%29.77M--8.71M--7.85M--6.38M--6.84M146.87%14.02M274.65%5.68M
-Selling and marketing expense 210.51%3.55M650.96%3.52M559.39%4.08M137.33%4.06M--1.83M--1.14M--469K--618K74.92%1.71M7,121.27%977K
-General and administrative expense 104.60%13.73M99.39%11.78M52.52%9.49M108.96%25.72M--6.88M--6.71M--5.91M--6.22M161.83%12.31M212.96%4.7M
Research and development costs -17.68%35.7M11.76%38.38M4.97%42.43M83.79%159.42M--41.29M--43.37M--34.34M--40.42M199.39%86.74M482.37%28.97M
Operating profit 50.57%-23.87M-31.79%-51.4M-41.32%-54.59M-9,149.35%-175.11M-49.2M-48.28M-39M-38.63M105.58%1.94M-433.78%-34.65M
Net non-operating interest income expense 85.43%3.31M226.81%3.69M876.60%2.19M159.20%3.42M789K1.78M1.13M-282K-684.12%-5.78M-21.05%-737K
Non-operating interest income 45.24%4.44M5.57%4.87M226.94%3.08M--11.28M--2.67M--3.06M--4.61M--943K--0--0
Non-operating interest expense --------------0-----------------30.17%287K-2.86%411K
Total other finance cost -10.98%1.14M-66.21%1.18M-27.10%893K43.15%7.86M--1.88M--1.28M--3.48M--1.23M1,584.66%5.49M75.53%326K
Other net income (expense) 717.03%3.91M2,161.14%8.7M-1,231.02%-41.37M72.19%-5.23M-1.06M-634K-422K-3.11M-193.73%-18.79M-21,770.90%-6.4M
Gain on sale of security 717.03%3.91M2,161.14%8.7M-1,231.02%-41.37M51.56%-5.23M---1.06M---634K---422K---3.11M-732.36%-10.79M5,679.36%1.71M
Special income (charges) --------------0------------------0---883K
-Less:Other special charges --------------------------------------883K
Other non- operating income (expenses) ---------------------------------10.83%-8M---7.22M
Income before tax 64.68%-16.65M-1.87%-39.01M-123.16%-93.77M-681.61%-176.91M-49.47M-47.13M-38.29M-42.02M45.83%-22.63M-490.94%-41.79M
Income tax -1K0027K27K00000
Net income 64.68%-16.65M-1.87%-39.01M-123.16%-93.77M-681.73%-176.94M-49.5M-47.13M-38.29M-42.02M45.83%-22.63M-490.94%-41.79M
Net income continuous Operations 64.68%-16.65M-1.87%-39.01M-123.16%-93.77M-681.73%-176.94M---49.5M---47.13M---38.29M---42.02M45.83%-22.63M-490.94%-41.79M
Minority interest income
Net income attributable to the parent company 64.68%-16.65M-1.87%-39.01M-123.16%-93.77M-681.73%-176.94M-49.5M-47.13M-38.29M-42.02M45.83%-22.63M-490.94%-41.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 64.68%-16.65M-1.87%-39.01M-123.16%-93.77M-681.73%-176.94M-49.5M-47.13M-38.29M-42.02M45.83%-22.63M-490.94%-41.79M
Basic earnings per share 68.42%-0.1812.77%-0.41-107.84%-1.06-80.67%-2.15-0.6-0.57-0.47-0.51-132.27%-1.19-490.94%-0.5123
Diluted earnings per share 68.42%-0.1812.77%-0.41-107.84%-1.06-80.67%-2.15-0.6-0.57-0.47-0.51-132.27%-1.19-490.94%-0.5123
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.